Ignite Planners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Sell
24,414
-296
-1% -$17K 0.19% 129
2026
Q1
$1.49M Buy
24,710
+249
+1% +$14.5K 0.23% 109
2025
Q4
$1.35M Buy
+24,461
New +$1.18M 0.21% 115
2025
Q2
Sell
-6,224
Closed -$309K 358
2025
Q1
$309K Buy
+6,224
New +$363K 0.06% 265
2024
Q2
Sell
-3,868
Closed -$205K 292
2024
Q1
$205K Sell
3,868
-134
-3% -$6.83K 0.06% 268
2023
Q4
$211K Sell
4,002
-2,144
-35% -$113K 0.06% 264
2023
Q3
$347K Sell
6,146
-1,720
-22% -$105K 0.11% 208
2023
Q2
$493K Buy
7,866
+180
+2% +$12.1K 0.19% 121
2023
Q1
$540K Buy
7,686
+587
+8% +$41.4K 0.22% 114
2022
Q4
$516K Buy
7,099
+387
+6% +$29.2K 0.22% 121
2022
Q3
$472K Buy
6,712
+948
+16% +$68.8K 0.38% 78
2022
Q2
$434K Sell
5,764
-921
-14% -$70.1K 0.36% 88
2022
Q1
$506K Buy
6,685
+627
+10% +$42.1K 0.34% 83
2021
Q4
$393K Buy
+6,058
New +$355K 0.26% 113

Other funds holding BMY

Ignite Planners's BMY Position: Q2 2026 in Review

Ignite Planners reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q2 2026, selling an estimated $17K and leaving 24,414 shares worth $1.41M. The position accounts for 0.19% of the portfolio, ranked #129.

Ignite Planners first reported a position in BMY in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.49M in Q1 2026. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Ignite Planners held 24,414 shares of Bristol-Myers Squibb worth $1.41M as of Q2 2026.
  • Ignite Planners sold 296 Bristol-Myers Squibb shares in Q2 2026, an estimated $17K.
  • Bristol-Myers Squibb made up 0.19% of Ignite Planners's portfolio in Q2 2026, its #129 holding.
  • Ignite Planners first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 14 quarters since.
  • Ignite Planners's Bristol-Myers Squibb position peaked at $1.49M in Q1 2026.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ignite Planners's 13F filing for Q2 2026, filed 23 Jul 2026.